DarioHealth Corp. (DRIO)
DarioHealth Statistics
Share Statistics
DarioHealth has 41.57M shares outstanding. The number of shares has increased by 40.38% in one year.
| Shares Outstanding | 41.57M |
| Shares Change (YoY) | 40.38% |
| Shares Change (QoQ) | 27.17% |
| Owned by Institutions (%) | 19.19% |
| Shares Floating | 29.78M |
| Failed to Deliver (FTD) Shares | 60.44K |
| FTD / Avg. Volume | 7.98% |
Short Selling Information
The latest short interest is 3.06M, so 7.98% of the outstanding shares have been sold short.
| Short Interest | 3.06M |
| Short % of Shares Out | 7.98% |
| Short % of Float | 10.3% |
| Short Ratio (days to cover) | 2.4 |
Valuation Ratios
The PE ratio is 1.29 and the forward PE ratio is -1.77. DarioHealth's PEG ratio is -0.01.
| PE Ratio | 1.29 |
| Forward PE | -1.77 |
| PS Ratio | 1.95 |
| Forward PS | 0.4 |
| PB Ratio | 0.73 |
| P/FCF Ratio | -1.36 |
| PEG Ratio | -0.01 |
Enterprise Valuation
DarioHealth Corp. has an Enterprise Value (EV) of 41.25M.
| EV / Earnings | 1.01 |
| EV / Sales | 1.53 |
| EV / EBITDA | -0.71 |
| EV / EBIT | -0.71 |
| EV / FCF | -1.07 |
Financial Position
The company has a current ratio of 1.72, with a Debt / Equity ratio of 0.42.
| Current Ratio | 1.72 |
| Quick Ratio | 1.72 |
| Debt / Equity | 0.42 |
| Total Debt / Capitalization | 29.54 |
| Cash Flow / Debt | -1.28 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 0.57% and return on capital (ROIC) is 0%.
| Return on Equity (ROE) | 0.57% |
| Return on Assets (ROA) | 0.34% |
| Return on Capital (ROIC) | 0% |
| Revenue Per Employee | $137,959.18 |
| Profits Per Employee | $209,091.84 |
| Employee Count | 196 |
| Asset Turnover | 0.23 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 40.98M |
| Effective Tax Rate | 1 |
Stock Price Statistics
The stock price has increased by -57.52% in the last 52 weeks. The beta is 1.42, so DarioHealth's price volatility has been higher than the market average.
| Beta | 1.42 |
| 52-Week Price Change | -57.52% |
| 50-Day Moving Average | 0.67 |
| 200-Day Moving Average | 0.89 |
| Relative Strength Index (RSI) | 46.03 |
| Average Volume (20 Days) | 757.57K |
Income Statement
In the last 12 months, DarioHealth had revenue of 27.04M and earned 40.98M in profits. Earnings per share was 0.61.
| Revenue | 27.04M |
| Gross Profit | 13.27M |
| Operating Income | -57.74M |
| Net Income | 40.98M |
| EBITDA | -57.74M |
| EBIT | -57.74M |
| Earnings Per Share (EPS) | 0.61 |
Balance Sheet
The company has 27.76M in cash and 30.19M in debt, giving a net cash position of -2.43M.
| Cash & Cash Equivalents | 27.76M |
| Total Debt | 30.19M |
| Net Cash | -2.43M |
| Retained Earnings | -390.34M |
| Total Assets | 118.88M |
| Working Capital | 23.89M |
Cash Flow
In the last 12 months, operating cash flow was -38.56M and capital expenditures -138K, giving a free cash flow of -38.7M.
| Operating Cash Flow | -38.56M |
| Capital Expenditures | -138K |
| Free Cash Flow | -38.7M |
| FCF Per Share | -0.58 |
Margins
Gross margin is 49.06%, with operating and profit margins of -213.55% and 151.56%.
| Gross Margin | 49.06% |
| Operating Margin | -213.55% |
| Pretax Margin | 151.56% |
| Profit Margin | 151.56% |
| EBITDA Margin | -213.55% |
| EBIT Margin | -213.55% |
| FCF Margin | -143.12% |
Dividends & Yields
DRIO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 93.85% |
| FCF Yield | -143.97% |
Analyst Forecast
The average price target for DRIO is $2, which is 207.7% higher than the current price. The consensus rating is "Buy".
| Price Target | $2 |
| Price Target Difference | 207.7% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Nov 18, 2019. It was a backward split with a ratio of 1:20.
| Last Split Date | Nov 18, 2019 |
| Split Type | backward |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | -5.38 |
| Piotroski F-Score | 3 |